These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 15660048)

  • 1. Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.
    Deedwania PC; Giles TD; Klibaner M; Ghali JK; Herlitz J; Hildebrandt P; Kjekshus J; Spinar J; Vitovec J; Stanbrook H; Wikstrand J;
    Am Heart J; 2005 Jan; 149(1):159-67. PubMed ID: 15660048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).
    Gullestad L; Wikstrand J; Deedwania P; Hjalmarson A; Egstrup K; Elkayam U; Gottlieb S; Rashkow A; Wedel H; Bermann G; Kjekshus J;
    J Am Coll Cardiol; 2005 Jan; 45(2):252-9. PubMed ID: 15653024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial.
    Caro JJ; Migliaccio-Walle K; O'Brien JA; Nova W; Kim J; Hauch O; Hillson E; Wedel H; Hjalmarson A; Gottlieb S; Deedwania PC; Wikstrand J;
    J Card Fail; 2005 Dec; 11(9):647-56. PubMed ID: 16360958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.
    Wedel H; Demets D; Deedwania P; Fagerberg B; Goldstein S; Gottlieb S; Hjalmarson A; Kjekshus J; Waagstein F; Wikstrand J;
    Am Heart J; 2001 Sep; 142(3):502-11. PubMed ID: 11526365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, safety and tolerability of beta-adrenergic blockade with metoprolol CR/XL in elderly patients with heart failure.
    Deedwania PC; Gottlieb S; Ghali JK; Waagstein F; Wikstrand JC;
    Eur Heart J; 2004 Aug; 25(15):1300-9. PubMed ID: 15288157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: experiences from MERIT-HF.
    Jánosi A; Ghali JK; Herlitz J; Czuriga I; Klibaner M; Wikstrand J; Hjalmarson A;
    Am Heart J; 2003 Oct; 146(4):721-8. PubMed ID: 14564329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials.
    Haas SJ; Vos T; Gilbert RE; Krum H
    Am Heart J; 2003 Nov; 146(5):848-53. PubMed ID: 14597934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The large-scale placebo-controlled beta-blocker studies in systolic heart failure revisited: results from CIBIS-II, COPERNICUS and SENIORS-SHF compared with stratified subsets from MERIT-HF.
    Wikstrand J; Wedel H; Castagno D; McMurray JJ
    J Intern Med; 2014 Feb; 275(2):134-43. PubMed ID: 24118421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mortality effect of metoprolol CR/XL in patients with heart failure: results of the MERIT-HF Trial.
    Goldstein S; Hjalmarson A
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V30-5. PubMed ID: 10526701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.
    Hjalmarson A; Goldstein S; Fagerberg B; Wedel H; Waagstein F; Kjekshus J; Wikstrand J; El Allaf D; Vítovec J; Aldershvile J; Halinen M; Dietz R; Neuhaus KL; Jánosi A; Thorgeirsson G; Dunselman PH; Gullestad L; Kuch J; Herlitz J; Rickenbacher P; Ball S; Gottlieb S; Deedwania P
    JAMA; 2000 Mar; 283(10):1295-302. PubMed ID: 10714728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).
    Ghali JK; Piña IL; Gottlieb SS; Deedwania PC; Wikstrand JC;
    Circulation; 2002 Apr; 105(13):1585-91. PubMed ID: 11927527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of beta-blockers for heart failure in patients with diabetes mellitus.
    Giles TD
    Postgrad Med; 2002 Nov; 112(5 Suppl Unanswered):32-7. PubMed ID: 19667606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).
    Wikstrand J; Wedel H; Ghali J; Deedwania P; Fagerberg B; Goldstein S; Gottlieb S; Hjalmarson A; Kjekshus J; Waagstein F
    Card Electrophysiol Rev; 2003 Sep; 7(3):264-75. PubMed ID: 14739726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF).
    Lancet; 1999 Jun; 353(9169):2001-7. PubMed ID: 10376614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consistency of ss-blocker effect across various subgroups with heart failure: insights from the MERIT-HF trial.
    Wikstrand J; Ghali JK; Goldstein S
    Postgrad Med; 2002 Nov; 112(5 Suppl Unanswered):16-23. PubMed ID: 19667604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF).
    Ghali JK; Wikstrand J; Van Veldhuisen DJ; Fagerberg B; Goldstein S; Hjalmarson A; Johansson P; Kjekshus J; Ohlsson L; Samuelsson O; Waagstein F; Wedel H;
    J Card Fail; 2009 May; 15(4):310-8. PubMed ID: 19398079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET).
    Torp-Pedersen C; Metra M; Charlesworth A; Spark P; Lukas MA; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Remme WJ; Scherhag A;
    Heart; 2007 Aug; 93(8):968-73. PubMed ID: 17237130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery.
    Juul AB; Wetterslev J; Kofoed-Enevoldsen A; Callesen T; Jensen G; Gluud C;
    Am Heart J; 2004 Apr; 147(4):677-83. PubMed ID: 15077084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of metoprolol CR/XL on mortality and hospitalizations in patients with heart failure and history of hypertension.
    Herlitz J; Wikstrand J; Denny M; Fenster P; Heywood T; Masszi G; Rasmussen S; Thorgeirsson G; Wachtell K;
    J Card Fail; 2002 Feb; 8(1):8-14. PubMed ID: 11862577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metoprolol controlled release/extended release in patients with severe heart failure: analysis of the experience in the MERIT-HF study.
    Goldstein S; Fagerberg B; Hjalmarson A ; Kjekshus J; Waagstein F; Wedel H; Wikstrand J;
    J Am Coll Cardiol; 2001 Oct; 38(4):932-8. PubMed ID: 11583861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.